CANCER TARGETED TECHNOLOGY LLC — Federal Contracts, Awards & Government Contractor Profile

About CANCER TARGETED TECHNOLOGY LLC

Cancer Targeted Technology (CTT) is a biotechnology company developing innovative small molecule drugs that target Prostate-Specific Membrane Antigen (PSMA) for the detection, stratification, and treatment of prostate and other cancers. CTT's agents are designed to improve patient survival and quality of life by delivering diagnostic and therapeutic payloads effectively to tumor sites.

Design and patenting of small molecule drugs for cancerDevelopment of diagnostic imaging agents (e.g., CTT1057 PET Imaging Agent)Creation of radiotherapeutic drugs (e.g., CTT1403)Development of chemotherapeutic drugs (e.g., CTT2274)Targeting of Prostate-Specific Membrane Antigen (PSMA) for cancer detection and treatment

Is this your company?

Claim CANCER TARGETED TECHNOLOGY LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim CANCER TARGETED TECHNOLOGY LLC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.